Inhibition of EGF-mediated receptor activity and cell proliferation by HK1-ceramide, a stable analog of the ganglioside GM3-lactone.

Gangliosides have been described as modulators of growth factor receptor activity and subsequent cellular function. Due to the lower-pH environment found in tumor cells, ganglosides are thought to be formed (at least to some extent) into their lactone forms. The aim of the study was to analyze the mode of action of the lactone of the ganglioside GM3 on epidermal growth factor (EGF) signaling in human ovarial epidermoid carcinoma A431 cells and cell growth in human oral epidermoid carcinoma KB cells by applying the GM3 lactone analog HK1-ceramide 2, which is stable under hydrolytic conditions. Specific inhibition of EGF-dependent receptor tyrosine phosphorylation was observed by HK1-ceramide 2 at 25 microM, whereas GM3 showed a comparable inhibition at eightfold higher concentrations. In cells exposed to low pH, where GM3 is thought to form its lactone to a higher extent, addition of GM3 showed no further inhibitory effect on EGF-dependent receptor phosphorylation. Similarly to GM3, HK1-ceramide 2 does not affect binding of (125)I-EGF to the cell surface receptor. EGF-dependent growth of KB cells was also found to be inhibited by HK1-ceramide 2 at much lower concentrations compared to GM3. In conclusion, our results indicate that the GM3 lactone analog HK1-ceramide 2 is a specific inhibitor of EGF receptor function and is more potent in reducing EGF-dependent tyrosine phosphorylation of the receptor in A431 cells and in inhibiting EGF-dependent growth of KB cells compared to GM3.

[1]  A. Zurita,et al.  Modulation of epidermal growth factor receptor phosphorylation by endogenously expressed gangliosides. , 2001, The Biochemical journal.

[2]  C. Janssen,et al.  Synthesis of a novel ether-bridged GM3-lactone analogue as a target for an antibody-based cancer therapy. , 2000, Chemistry.

[3]  E. Meuillet,et al.  Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431. , 2000, Experimental cell research.

[4]  R. Cole,et al.  Structural characterization of gangliosides isolated from mullet milt using electrospray ionization-tandem mass spectrometry. , 1999, Glycobiology.

[5]  K. Nagata,et al.  Binding affinity of GM3 lactone for influenza virus , 1999, Glycoconjugate Journal.

[6]  J. Lucocq,et al.  Low extracellular pH induces activation of ERK 2, JNK, and p38 in A431 and Swiss 3T3 cells. , 1997, Biochemical and biophysical research communications.

[7]  C. Cordon-Cardo,et al.  Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides , 1997, International journal of cancer.

[8]  C. Cordon-Cardo,et al.  Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group‐related antigens , 1997, International journal of cancer.

[9]  L. Tietze,et al.  Synthesis of a Novel Stable GM3‐Lactone Analogue as Hapten for a Possible Immunization against Cancer , 1997 .

[10]  S. Hakomori.  Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. , 1996, Cancer research.

[11]  D. Soulières,et al.  Gangliosides in human uveal melanoma metastatic process , 1996, International journal of cancer.

[12]  A. Rebbaa,et al.  Ganglioside GM3 inhibition of EGF receptor mediated signal transduction. , 1996, Glycobiology.

[13]  S. Tsukamoto,et al.  An efficient short-step total synthesis of ganglioside GM3: effective usage of the neighbouring group participation strategy. , 1996, Carbohydrate research.

[14]  Yuan-chuan Lee,et al.  Carbohydrate-Protein Interactions: Basis of Glycobiology , 1995 .

[15]  E. Goldsmith,et al.  How MAP Kinases Are Regulated (*) , 1995, The Journal of Biological Chemistry.

[16]  M. Suzuki,et al.  Generation of monoclonal antibodies specific for ganglioside lactones: Evidence of the expression of lactone on human melanoma cells , 1994, International journal of cancer.

[17]  S. Hakomori,et al.  GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction. , 1994, The Journal of biological chemistry.

[18]  Diatlovitskaia Ev,et al.  Ganglioside lactones in human stomach and breast tumors , 1993 .

[19]  R. Davis,et al.  Regulation of epidermal growth factor receptor signal transduction. Role of gangliosides. , 1990, The Journal of biological chemistry.

[20]  S. Hakomori,et al.  Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor. , 1988, The Journal of biological chemistry.

[21]  S. Hakomori,et al.  Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen. , 1987, Journal of immunology.

[22]  J. Mendelsohn,et al.  Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. C. King,et al.  Resolution of high and low affinity epidermal growth factor receptors. Inhibition of high affinity component by low temperature, cycloheximide, and phorbol esters. , 1982, The Journal of biological chemistry.

[24]  I. C. O. B. Nomenclature.  Tentative rules for carbohydrate nomenclature. Part 1, 1969 , 1971 .

[25]  L. Svennerholm.  CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES * , 1963, Journal of neurochemistry.

[26]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[27]  A. Rebbaa,et al.  Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431. , 1999, Cancer research.

[28]  P. Cornaglia-Ferraris,et al.  Angiogenic and angiostatic microenvironment in tumors--role of gangliosides. , 1997, Acta oncologica.

[29]  U. Greiser,et al.  Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: involvement of receptor-directed protein tyrosine phosphatase(s). , 1997, British Journal of Cancer.

[30]  Eric G. Bremer,et al.  Chapter 15 - Glycosphingolipids as Effectors of Growth and Differentiation , 1994 .

[31]  E. V. Diatlovitskaia,et al.  [Ganglioside lactones in human stomach and breast tumors]. , 1993, Biokhimiia.

[32]  H. Oettgen.  Gangliosides and cancer , 1989 .

[33]  J. Schlessinger,et al.  Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. , 1986, The Journal of biological chemistry.